Tuesday, October 20, 2020
Home Tags MCN-03-Jun-2020

MCN-03-Jun-2020 Related News

Cannabis medicine, education, and policy in Switzerland

Cannabis medicine, education, and policy in Switzerland

Professor Rudolf Brenneisen of the Swiss Society of Cannabis in Medicine tells us about medical cannabis in Switzerland. The Swiss Society of Cannabis in Medicine...
Medical cannabis in North Macedonia

Medical cannabis in North Macedonia

Kostadin Dukovski, President of North Macedonia’s Association of Medical Cannabis Cultivators, tells MCN about Macedonian policy, economy and future developments. The Association of Medical Cannabis...
Education and regulation for the EU cannabis market

Education and regulation for the EU cannabis market

James O’Dowd, Secretary General of the European Alliance for Medicinal Cannabis, talks cannabis policy and oversight in the EU cannabis market. The European Alliance for...
Medical Cannabis Network Quarterly Issue 3

Medical Cannabis Network Quarterly Issue 3

Medical Cannabis Network Quarterly editor Rosemary Lobley introduces our third edition, which looks at cannabis research, policy, and national and international regulation of cannabis. Welcome...
Discover the EUMCA with Professor Trevor Jones

Discover the EUMCA with Professor Trevor Jones

Professor Trevor Jones, Chairman of the European Medicinal Cannabis Association, tells MCN Digital Editor Stephanie Price about CBD quality standards, education and evidence-based policy. Formed...
Shaping the future of German cannabis

Shaping the future of German cannabis

MCN speaks to Jürgen Neumeyer, Branchenverband Cannabiswirtschaft Managing Director, about the German cannabis landscape. Branchenverband Cannabiswirtschaft, the German Cannabis Business Association, aims to represent all...
Novel Food Consortium to protect Europe’s hemp industry

Novel Food Consortium to protect Europe’s hemp industry

The European Industrial Hemp Association has launched an industry consortium to share the burden of Novel Foods applications. In the face of disparate and inconsistent...
Normal people: cannabis and policy in Norway

Normal people: cannabis and policy in Norway

Ester Nafstad, Manager of Norwegian cannabis advocacy body Normal, tells MCN publication about the chapter’s goals and the need for reform of cannabis policy...
From plant to patients: pharmaceutical grade cannabis solutions

From plant to patients: pharmaceutical grade cannabis solutions

Combining the best of science and agritech to pave the path for pharmaceutical grade cannabis solutions. Natural products have been the backbone of traditional healing...
Expanding the boundaries of medical cannabis clinical evidence

Expanding the boundaries of medical cannabis clinical evidence

Expanding the boundaries of medical cannabis clinical evidence; removing barriers to medical cannabis practice. In this article, Amit Sade, of Sade Group, discusses expanding medical...
Shipping medical cannabis: a Dutch perspective

Shipping medical cannabis: a Dutch perspective

Malti Ramdharie of CIBG tells MCN about the shipping and supply of medical cannabis in the Netherlands. Dutch patients have been able to access medical...
How have Cannabis 2.0 and COVID-19 affected the industry?

How have Cannabis 2.0 and COVID-19 affected the industry?

Cannabis Council of Canada President and CEO George Smitherman tells MCN about the Cannabis 2.0 rollout, COVID-19, and the future of Canadian cannabis policy. In...

Health Special Reports

Health eBooks

Health Partners

Pin It on Pinterest